Sasha Damouni | Vice President, Investor Relations and Corporate Communications |
Scott Braunstein | Chief Executive Officer |
Joe Hulihan | Chief Medical Officer |
Christy Shafer | Chief Commercial Officer |
Steve Pfanstiel | Chief Financial Officer |
Kimberly McCormick | Vice President, Regulatory Affairs |
Joe Thome | Cowen & Company |
Alethia Young | Cantor Fitzgerald |
Joon Lee | Truist Securities |
Marc Goodman | SVB Leerink |
Douglas Tsao | H.C. Wainwright |
Jay Olson | Oppenheimer |
Brian Skorney | Baird |
Michael Higgins | Ladenburg Thalmann |
Andrew Tsai | Jefferies |
Jason Butler | JMP Securities |
Greetings and welcome to the Marinus Pharmaceuticals First Quarter 2021 Business Update Call. [Operator Instructions] And it is now my pleasure to introduce to your host, Sasha Damouni, Vice President of Investor Relations and Corporate Communications.
You may begin, Ms. Damouni.
Thank you.